PMID: 2412947
A British study examined diabetic complications in 1148 hypertensive subjects with type 2 diabetes (average age 56 and average blood pressure 160/94 mm Hg at baseline) over an average follow-up period of 8.4 years
These preclinical results were supported by genome-wide association studies, which have identified variants with reduced activity at the human GIP receptor locus that are associated with reduced BMI [72]
Evidence from clinical and preclinical studies suggests that disruption of the HPA axis and changes in GR and MR balance are involved in the ES-induced behavioral alterations and the increased risk to develop psychopathologies later in life [162, 205,206,207,208]
95% CI 0.89, 0.96), compared with other second- or third-line glucose-lowering medications
In our clinical experience, we have seen strong results with Semaglutide GLP-1, particularly when it is used in conjunction with a reduced-calorie diet and regular exercise